Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 1
2006 1
2007 1
2008 1
2009 3
2010 5
2011 7
2012 8
2013 22
2014 30
2015 27
2016 31
2017 46
2018 47
2019 57
2020 61
2021 13
Text availability
Article attribute
Article type
Publication date

Search Results

326 results
Results by year
Filters applied: . Clear all
Page 1
The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).
Safari Z, Gérard P. Safari Z, et al. Cell Mol Life Sci. 2019 Apr;76(8):1541-1558. doi: 10.1007/s00018-019-03011-w. Epub 2019 Jan 25. Cell Mol Life Sci. 2019. PMID: 30683985 Review.
NAFLD is currently the main cause of chronic liver disease in developed countries, and the number of NAFLD patients is growing worldwide. ...Recently, the role of the gut microbiota in the pathophysiology of many diseases has been revealed. Regarding
NAFLD is currently the main cause of chronic liver disease in developed countries, and the number of NAFLD patie
The role of the gut microbiota in NAFLD.
Leung C, Rivera L, Furness JB, Angus PW. Leung C, et al. Nat Rev Gastroenterol Hepatol. 2016 Jul;13(7):412-25. doi: 10.1038/nrgastro.2016.85. Epub 2016 Jun 8. Nat Rev Gastroenterol Hepatol. 2016. PMID: 27273168 Review.
NAFLD is now the most common cause of liver disease in Western countries. ...Evidence also suggests that certain food components and lifestyle factors, which are known to influence the severity of NAFLD, do so at least in part by changing the gut micro
NAFLD is now the most common cause of liver disease in Western countries. ...Evidence also suggests that certain food c
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Xie C, Halegoua-DeMarzio D. Xie C, et al. Nutrients. 2019 Nov 19;11(11):2837. doi: 10.3390/nu11112837. Nutrients. 2019. PMID: 31752378 Free PMC article. Review.
Non-alcoholic fatty liver disease (NAFLD) is the hepatic consequence of metabolic syndrome, which often also includes obesity, diabetes, and dyslipidemia. ...Due to the hypothesis that probiotics/synbiotics could normalize GM and r
Non-alcoholic fatty liver disease (NAFLD) is the hepatic consequence of metabolic syndrome, which
Probiotics in digestive diseases: focus on Lactobacillus GG.
Pace F, Pace M, Quartarone G. Pace F, et al. Minerva Gastroenterol Dietol. 2015 Dec;61(4):273-92. Minerva Gastroenterol Dietol. 2015. PMID: 26657927 Review.
Many of these are available in a lyophilized (freeze-dried) pill form, though some are available in yogurt or as packets (sachets), which can be mixed into non-carbonated drinks. The present review focuses on three main issues: 1) understanding why, at present, probioti
Many of these are available in a lyophilized (freeze-dried) pill form, though some are available in yogurt or as packets (sachets), which ca …
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD.
Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Perumpail BJ, et al. Diseases. 2019 Feb 25;7(1):27. doi: 10.3390/diseases7010027. Diseases. 2019. PMID: 30823570 Free PMC article. Review.
Recent breakthrough in our understanding pertaining to the pathogenesis of nonalcoholic fatty liver disease (NAFLD) has pointed to dysregulation or derangement of the gut microbiome, also known as dysbiosis. ...Future research is necessary to assess th …
Recent breakthrough in our understanding pertaining to the pathogenesis of nonalcoholic fatty liver disease (NAFLD
Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials.
Sáez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, Plaza-Diaz J, Gil A. Sáez-Lara MJ, et al. Int J Mol Sci. 2016 Jun 13;17(6):928. doi: 10.3390/ijms17060928. Int J Mol Sci. 2016. PMID: 27304953 Free PMC article. Review.
The present study reviews the effects of probiotics and synbiotics on obesity, insulin resistance syndrome (IRS), type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD) in human randomized clinical trials. ...Some p
The present study reviews the effects of probiotics and synbiotics on obesity, insulin resistance syndrome (IRS), type 2 diabetes (T2 …
The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies.
Meroni M, Longo M, Dongiovanni P. Meroni M, et al. Nutrients. 2019 Nov 4;11(11):2642. doi: 10.3390/nu11112642. Nutrients. 2019. PMID: 31689910 Free PMC article. Review.
Nonalcoholic fatty liver disease (NAFLD) encompasses a broad spectrum of pathological hepatic conditions ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), which may predispose to liver cirrhosis and hepatocellular carcinoma ( …
Nonalcoholic fatty liver disease (NAFLD) encompasses a broad spectrum of pathological hepatic conditions ranging …
Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives.
Hu H, Lin A, Kong M, Yao X, Yin M, Xia H, Ma J, Liu H. Hu H, et al. J Gastroenterol. 2020 Feb;55(2):142-158. doi: 10.1007/s00535-019-01649-8. Epub 2019 Dec 16. J Gastroenterol. 2020. PMID: 31845054 Free PMC article. Review.
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of dysregulated lipid and glucose metabolism, which is often associated with obesity, dyslipidemia and insulin resistance. In view of the high morbidity and health ris
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of dysregulated lipid and g
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH).
Duarte SMB, Stefano JT, Oliveira CP. Duarte SMB, et al. Ann Hepatol. 2019 May-Jun;18(3):416-421. doi: 10.1016/j.aohep.2019.04.006. Epub 2019 Apr 16. Ann Hepatol. 2019. PMID: 31036494 Free article. Review.
Genetic predisposition, the intestinal microbiota (IM) and environmental factors, such as sedentary lifestyle and inadequate diet, should be considered as critical factors for the development of nonalcoholic fatty liver disease (NAFLD). Recently, some …
Genetic predisposition, the intestinal microbiota (IM) and environmental factors, such as sedentary lifestyle and inadequate diet, should be …
Pediatric NAFLD: the Future role of Patient-Tailored Probiotics Therapy.
Putignani L, Alisi A, Nobili V. Putignani L, et al. J Pediatr Gastroenterol Nutr. 2016 Jul;63 Suppl 1:S6-8. doi: 10.1097/MPG.0000000000001220. J Pediatr Gastroenterol Nutr. 2016. PMID: 27380600 Review.
PURPOSE OF REVIEW: Clinical evidence of the use of probiotics in pediatric NAFLD, framed within gut microbiota response, is herein discussed. ...SUMMARY: Epidemiology suggests that NAFLD is the most frequent pediatric chronic liver disease evolv …
PURPOSE OF REVIEW: Clinical evidence of the use of probiotics in pediatric NAFLD, framed within gut microbiota response, is he …
326 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page